Literature DB >> 15362064

An increasing incidence of cholangiocarcinoma: why?

Laurie Blendis, Zamir Halpern.   

Abstract

Entities:  

Year:  2004        PMID： 15362064     DOI： 10.1053/j.gastro.2004.07.035

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

1.  Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.

Authors:  Domenico Alvaro; Barbara Barbaro; Antonio Franchitto; Paolo Onori; Shannon S Glaser; Gianfranco Alpini; Heather Francis; Luca Marucci; Paola Sterpetti; Stefano Ginanni-Corradini; Andrea Onetti Muda; David E Dostal; Adriano De Santis; Adolfo F Attili; Antonio Benedetti; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

2.  Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.

Authors:  Nisana Tepsiri; Liengchai Chaturat; Banchob Sripa; Wises Namwat; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Wichittra Tassaneeyakul
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  New insights on cholangiocarcinoma.

Authors:  Manuela Gatto; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

4.  Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.

Authors:  Bo-Ra Yun; Mi-Jin Lee; Jong-Hyun Kim; In-Hee Kim; Goung-Ran Yu; Dae-Ghon Kim
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

5.  Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity.

Authors:  Timothy Miller; Fuquan Yang; Candace E Wise; Fanyin Meng; Sally Priester; Md Kamruzzaman Munshi; Micheleine Guerrier; David E Dostal; Shannon S Glaser
Journal:  Dig Liver Dis       Date:  2011-02-21       Impact factor: 4.088

6.  Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma.

Authors:  Andreas Weber; Claus von Weyhern; Falko Fend; Jochen Schneider; Bruno Neu; Alexander Meining; Hans Weidenbach; Roland M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

7.  Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA.

Authors:  Ke Xiao; Zhengxiao Ouyang; Hui-Huan Tang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

8.  Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?

Authors:  E Buc; M Lesurtel; J Belghiti
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor.

Authors:  A Mancino; M G Mancino; S S Glaser; G Alpini; A Bolognese; L Izzo; H Francis; P Onori; A Franchitto; S Ginanni-Corradini; E Gaudio; D Alvaro
Journal:  Dig Liver Dis       Date:  2008-04-18       Impact factor: 4.088

10.  Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.

Authors:  Min-A Seol; In-Sun Chu; Mi-Jin Lee; Goung-Ran Yu; Xiang-Dan Cui; Baik-Hwan Cho; Eun-Kyung Ahn; Sun-Hee Leem; In-Hee Kim; Dae-Ghon Kim
Journal:  BMC Cancer       Date:  2011-02-19       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.